Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis

Elda Righi(Ospedale Santa Maria della Misericordia di Udine), David L. Paterson(The University of Queensland), Mariana Pitombeira Libório(Universidade de Fortaleza), Patrick N. A. Harris(The University of Queensland), Alexander M. Wailan(University of Queensland), Anna Maria Peri(The University of Queensland), Steven Lane(QIMR Berghofer Medical Research Institute)
Journal of Antimicrobial Chemotherapy
September 30, 2016
10.1093/jac/dkw459
Cited by 114

Related Papers

Antimicrobial Resistance in ESKAPE Pathogens
|Clinical Microbiology Reviews|2020|2k
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance
|JAMA|2018|761
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
|Nature Reviews Urology|2015|367
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351